Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Breast Neoplasms
  • Neoplasm Staging

abstract

  • The current study validates the CPS + EG staging system in two independent cohorts. We recommend that biologic markers and response to treatment be incorporated into revised versions of the AJCC staging system for patients receiving neoadjuvant chemotherapy.

publication date

  • May 20, 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3107758

Digital Object Identifier (DOI)

  • 10.1200/JCO.2010.31.8469

PubMed ID

  • 21482989

Additional Document Info

start page

  • 1956

end page

  • 62

volume

  • 29

number

  • 15